The global coronary stent market is expected to grow from USD 7,756 million in 2018 to USD 13,907 million in 2025, at a CAGR of 8.7% from 2019 to 2025. The growth in the market is attributed to the increasing prevalence of coronary artery diseases and heart valve disorders, and technological advancement in coronary stents. Moreover, growing demand for drug-eluting stents and biodegradable polymer-coated coronary stents, favorable reimbursement policies, and growing government support and new product launches are further propelling the industry growth.
Coronary stent is a small, metal mesh that expands inside a coronary artery. It has been used to treat coronary artery diseases for more than a decade. These stents hold a coronary artery open and maintain blood flow after an angioplasty. Currently, more than 2 million people get a coronary stent each year. The years used for the assessment are as follows:
Historical year: 2015, 2016, 2017
Base year: 2018
Forecast period: 2019 – 2025
RESEARCH METHODOLOGY
The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;
OBJECTIVES:
CHAPTER 1. Market Scope and Methodology
1.1. Research methodology
1.2. Research scope & assumptions
1.3. List of data sources
CHAPTER 2. Executive Summary
2.1. Global Coronary Stent- Market Snapshot
CHAPTER 3. Industry Analysis
3.1. Market definition
3.2. Market segmentation
3.3. Key findings of the global coronary stent market
3.4. Value Chain Analysis
3.5. Market opportunities & trends
3.5.1. Favorable reimbursement policies
3.5.2. Growing demand for coronary stent in developing countries
3.5.3. Scientific research and development activities in drug-eluting stent systems
3.6. Market dynamics
3.6.1. Market driver analysis
3.6.1.1. Increasing prevalence of coronary artery diseases and heart valve disorders
3.6.1.2. Growing demand for drug-eluting stents and biodegradable polymer-coated coronary stents
3.6.1.3. Technological advancement in coronary stents
3.6.1.4. Growing government support and new product launches
3.6.2. Market restraint analysis
3.6.2.1. High cost associated with advance coronary stents
CHAPTER 4. Competitive Outlook
4.1. Company Market Share Analysis
4.2. Porters Five Forces Analysis
CHAPTER 5. Global Coronary Stent Market Size and Forecast (2015 – 2025)
5.1. Global Coronary Stent Market, By Product Type (USD Million)
5.1.1. Drug-Eluting Stents
5.1.2. Bioabsorbable Stents
5.1.3. Bare Metal Stents
5.2. Global Coronary Stent Market, By Material (USD Million)
5.2.1. Metallic
5.2.2. Polymeric
5.2.3. Natural
5.3. Global Coronary Stent Market, By Mode of Delivery (USD Million)
5.3.1. Self-Expanding Stents
5.3.2. Balloon-Expandable Stents
5.4. Global Coronary Stent Market, By End-user (USD Million)
5.4.1. Ambulatory Surgical Centers
5.4.2. Hospitals
5.4.3. Cardiac Centers
CHAPTER 6. Global Coronary Stent Market, By Geography
6.1. North America Coronary Stent Market
6.1.1. North America Coronary Stent Market, By Product Type (USD Million)
6.1.2. North America Coronary Stent Market, By Material (USD Million)
6.1.3. North America Coronary Stent Market, By Mode of Delivery (USD Million)
6.1.4. North America Coronary Stent Market, By End-user (USD Million)
6.1.5. North America Coronary Stent Market, By Country
6.1.5.1. The United States
6.1.5.2. Canada
6.1.5.3. Mexico
6.2. Europe Coronary Stent Market
6.2.1. Europe Coronary Stent Market, By Product Type (USD Million)
6.2.2. Europe Coronary Stent Market, By Material (USD Million)
6.2.3. Europe Coronary Stent Market, By Mode of Delivery (USD Million)
6.2.4. Europe Coronary Stent Market, By End-user (USD Million)
6.2.5. Europe Coronary Stent Market, By Country
6.2.5.1. France
6.2.5.2. U.K
6.2.5.3. Italy
6.2.5.4. Spain
6.2.5.5. Germany
6.2.5.6. Rest of Europe
6.3. Asia-Pacific Coronary Stent Market
6.3.1. Asia-Pacific Coronary Stent Market, By Product Type (USD Million)
6.3.2. Asia-Pacific Coronary Stent Market, By Material (USD Million)
6.3.3. Asia-Pacific Coronary Stent Market, By Mode of Delivery (USD Million)
6.3.4. Asia-Pacific Coronary Stent Market, By End-user (USD Million)
6.3.5. Asia-Pacific Coronary Stent Market, By Country
6.3.5.1. Australia
6.3.5.2. China
6.3.5.3. India
6.3.5.4. Japan
6.3.5.5. Rest of Asia-Pacific
6.4. Central & South America Coronary Stent Market
6.4.1. Central & South America Coronary Stent Market, By Product Type (USD Million)
6.4.2. Central & South America Coronary Stent Market, By Material (USD Million)
6.4.3. Central & South America Coronary Stent Market, By Mode of Delivery (USD Million)
6.4.4. Central & South America Coronary Stent Market, By End-user (USD Million)
6.4.5. Central & South America Coronary Stent Market, By Country
6.4.5.1. Argentina
6.4.5.2. Brazil
6.4.5.3. Rest of Central & South America
6.5. Middle East and Africa Coronary Stent Market
6.5.1. Middle East and Africa Coronary Stent Market, By Product Type (USD Million)
6.5.2. Middle East and Africa Coronary Stent Market, By Material (USD Million)
6.5.3. Middle East and Africa Coronary Stent Market, By Mode of Delivery (USD Million)
6.5.4. Middle East and Africa Coronary Stent Market, By End-user (USD Million)
6.5.5. Middle East and Africa Coronary Stent Market, By Country
6.5.5.1. Saudi Arabia
6.5.5.2. South Africa
6.5.5.3. Rest of Middle East and Africa
CHAPTER 7. Key Players and Strategic Developments
7.1. Terumo Corporation
7.1.1. Business Overview
7.1.2. Product and Service Offering
7.1.3. Financial Overview
7.1.4. Strategic Developments
7.2. Biotronik SE & Co. KG
7.2.1. Business Overview
7.2.2. Product and Service Offering
7.2.3. Financial Overview
7.2.4. Strategic Developments
7.3. Abbott Laboratories
7.3.1. Business Overview
7.3.2. Product and Service Offering
7.3.3. Financial Overview
7.3.4. Strategic Developments
7.4. Boston Scientific Corporation
7.4.1. Business Overview
7.4.2. Product and Service Offering
7.4.3. Financial Overview
7.4.4. Strategic Developments
7.5. B. BRAUN MELSUNGEN AG
7.5.1. Business Overview
7.5.2. Product and Service Offering
7.5.3. Financial Overview
7.5.4. Strategic Developments
7.6. MicroPort Scientific Corporation
7.6.1. Business Overview
7.6.2. Product and Service Offering
7.6.3. Financial Overview
7.6.4. Strategic Developments
7.7. Medtronic
7.7.1. Business Overview
7.7.2. Product and Service Offering
7.7.3. Financial Overview
7.7.4. Strategic Developments
7.8. C. R. Bard, Inc.
7.8.1. Business Overview
7.8.2. Product and Service Offering
7.8.3. Financial Overview
7.8.4. Strategic Developments
7.9. Stentys SA
7.9.1. Business Overview
7.9.2. Product and Service Offering
7.9.3. Financial Overview
7.9.4. Strategic Developments